Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
This study has been completed.
Study NCT00089765   Information provided by National Institutes of Health Clinical Center (CC)
First Received: August 12, 2004   Last Updated: August 16, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Von Hippel-Lindau Syndrome
Additional conditions recognized in this trial
Syndrome
Von Hippel-Lindau Disease
More general conditions related to this trial
Angiomatosis
Cardiovascular Diseases
Disease
Nervous System Diseases
Neurocutaneous Syndromes
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Ranibizumab
Sponsors listed in this trial
National Eye Institute (NEI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services